Bupa, the UKs leading private medical insurance provider, has published its annual report and financial statements for the year to 31 December 2012, showing revenues up by just 2% compared with Axa PPPs rising 4%. Bupa still has the much larger market share in terms of premium take, with gross premiums (minus outward reinsurance premiums) of £2,262.5m (2011: £2,243.7m). Taking out change in gross provision for unearned premiums of £13.3m (2011: £38.8m) and reinsurers share of change in the gross provision for unearned premiums of £28,000 (2011: £805,000), net premiums earned were £2,249.1m (2011: £2,204.8m). After other technical income, net of reinsurance, total technical income was £2,252.1m (2010: £2,208.1m). Claims incurred totalled £1,631.4m (2011: £1,613.5m). An underwriting contribution of £620.7m (2011: £594.7m) minus net operating expenses of £500.6m (£460.1m) meant the balance on the technical account was £120.1m (2011: £134.5m). Investment income and unrealised gains on investments (minus expenses and losses) were up to £36.0m (2011: £25.9m) meaning the profit before tax was £156.1m (2011: £160.3m).